Novavax COVID-19 Vaccine Nuvaxovid Recommended For Expanded Conditional Marketing Authorization In The European Union By CHMP For Adolescents Aged 12 Through 17; Nuvaxovid Demonstrated 80% Efficacy And Was Generally Well-Tolerated In Adolescents

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!